Naomi Jiang
YOU?
Author Swipe
View article: Infant Core-collapse Supernovae with Circumstellar Interactions from KMTNet. I. Luminous Transitional Case of KSP-SN-2022c
Infant Core-collapse Supernovae with Circumstellar Interactions from KMTNet. I. Luminous Transitional Case of KSP-SN-2022c Open
We present BVi multiband high-cadence observations of a Type II supernova (SN) KSP-SN-2022c from a star-forming galaxy at z ≃ 0.041 from its infant to nebular phase. Early light-curve fitting with a single power law is consistent with the …
View article: Infant Core-collapse Supernovae with Circumstellar Interactions from KMTNet I: Luminous Transitional Case of KSP-SN-2022c
Infant Core-collapse Supernovae with Circumstellar Interactions from KMTNet I: Luminous Transitional Case of KSP-SN-2022c Open
We present $BVi$ multi-band high-cadence observations of a Type II supernova (SN) KSP-SN-2022c from a star-forming galaxy at $z$ $\simeq$ 0.041 from its infant to nebular phase. Early light curve fitting with a single power-law is consiste…
View article: Cover Image
Cover Image Open
The cover image is based on the Original Research Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer by Soumon Rudra et al., DOI: 10.1002/cam4.2100.
View article: Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer
Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer Open
Background Adaptive magnetic resonance imaging‐guided radiation therapy (MRgRT) can escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of inoperable pancreatic cancer patients treated using MRgRT with and…
View article: Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer Open
In this study, stereotactic body radiotherapy for low-risk and intermediate-risk disease was associated with low rates of severe toxic events and high rates of biochemical control. These data suggest that stereotactic body radiotherapy is …